Dr. Burak GümüşçüAesthetic & Health Technologies
Hair Health

4 min read

Exosome Hair Therapy Side Effects: Expected and Reportable

Exosome hair therapy side effects: which findings are ordinary and which need reporting? A short plain guide to the subject for anyone weighing it up.

What helps with exosome hair therapy side effects is not lengthening the list but splitting it in two: ordinary findings from the procedure, and findings that need reporting without delay. This article separates the two groups.

Which findings are ordinary?

Short answer: Redness, tenderness, a feeling of tightness and small bumps on the scalp are ordinary findings. They belong to the procedure and fade quickly.

How marked the redness is varies with the technique used; applied alongside microneedling it can read more widely.

A mild burning or warm sensation is ordinary too and generally passes quickly.

What does the technique change?

With micro-injection the findings gather at the treated points; bumps are more noticeable in that group.

With microneedling a more widespread redness and mild flaking can be described.

Which technique is used is decided by the picture and shapes the period afterwards too.

How long do they last?

The marked phase is generally measured in hours; fully settling can take a little longer.

The factors are clear: the technique used, how wide the area was and the person's sensitivity.

So taking someone else's experience as your own timetable is misleading.

Which need reporting?

Short answer: Increasing pain, spreading redness in the area, fever, discharge and a change in skin colour are not expected findings and should be reported without delay.

What separates them is direction and timing. Ordinary findings are marked in the first hours and fade.

Widespread itching, a rash or facial swelling also need reporting.

Is there a risk of infection?

As with any treatment that breaks the skin barrier there is a possibility of infection; in a treatment carried out under appropriate conditions it is low.

What reduces the risk is clear: cleaning the area, single-use materials and the treatment being carried out by a doctor under appropriate conditions.

Not irritating the scalp in the first 24 hours reduces it too.

The product safety heading

The field being relatively new makes the choice of product a heading of its own.

The FDA consumer alert notes that this product group is unapproved.

Seeing the box and the expiry date is your right; product safety is covered separately.

What reduces the risk?

Short answer: The most decisive factor is who carries the treatment out and under what conditions. A treatment that breaks the skin barrier is a medical procedure.

The second is the pre-session briefing being complete; medicines and your health history should be asked about.

The third is following the instructions afterwards; who should avoid it and what it is are covered separately. The treatment's own page sits under exosome hair therapy.

Frequently asked questions

How long does the redness last? It varies with the technique used. Applied alongside microneedling a more widespread redness can be described; with micro-injection the findings gather at the treated points. The marked phase is generally measured in hours and settles on its own.

Will my hair shed more? A short-lived increase in shedding can be described afterwards and it is generally temporary. However a shedding that keeps increasing and persists is not in the same category; in that case the picture needs reassessing and the clinic should be told.

What should I do if a side effect appears? Tell the clinic and do not put it off. Rather than deciding over the phone whether a finding is expected, they may want to see the area. How to reach the clinic is told to you at the end of the session and you should not leave without that information.


If you would like to talk through which risks stand out in your own picture, the consultation reviews your health history and the scalp together.

This article is for general information and is not medical advice. Assessment and treatment decisions follow a medical examination; results vary between individuals.

References

  1. Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes — FDA
  2. Hair loss — NHS
  3. Türkiye İlaç ve Tıbbi Cihaz Kurumu (TİTCK)